Iran produces new drug to decrease premature death
Iranian researchers have produced a new type of medicine named 'Polypill' which helps reduction of premature death resulting from heart attack and stroke.
"One of the reasons for the Iranians' premature death is heart attack and stroke. We have made efforts in our research in the past 15 years to decrease the rate of premature death," Deputy Health Minister for Research and Technology Reza Malekzadeh told reporters in Tehran on Sunday.
"We could produce a new tablet which can increase the average lifetime of Iranians if consumed," he added.
Malekzadeh said that the medicine can reduce at least 50% of premature deaths resulting from heart attack and stroke, adding that it is now available in the country's markets and pharmacies.
Iran has taken wide strides in science and technology, particularly in medical and medicinal fields, in recent years.
The country has already mass-produced Doxorubicin - a non-carcinogenic drug - used in lung and breast cancer cases and made based on nano-liposomes technique. The drug with higher efficiency needs lower times for use and naturally lessens side effects, including vascular and heart complications.
Iran has also produced two other non-carcinogenic medicines Paclitaxel for breast and ovarian cancer and oxaliplatin for colon cancer.
Iran is among the very few countries which have developed a remedy for the most fearsome disease in the human community, known as AIDS. In 2007, Iranian scientists found a safe and effective cure for the dreaded virus, AIDS. This medicine made up of herbal and chemical components works to build immunity and enhance the quality of life of both AIDS and HIV-positive patients with no proven side effects.